Neogen Story Overview

NEOG -- USA Stock  

USD 90.44  0.78  0.86%

Macroaxis does not monitor all media channels or aggregates social signals for Neogen. But even though we do not provide professional-grade financial sentiment analysis on Neogen, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for Neogen. Please see also Neogen Hype Analysis, Neogen Correlation and Neogen Performance.
Exercise or conversion by Ronald Green of 3000 shares of Neogen subject to Rule 16b-3
Filed transaction by Neogen Corp director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Neogen Corporation insider trading alert for exercise of common stock (right to buy) by Ronald Green, the corporate stakeholder, on October 6, 2017. This event was filed by Neogen Corp with SEC on 2017-10-06. Statement of changes in beneficial ownership - SEC Form 4

Story Momentum

This media report from MacroaxisInsider distributed on October 6, 2017 was a factor to the next trading day price decrease.The trading delta at closing time against the next closing price was 0.55% . The trading delta at closing time when the story was published against the current closing price is 18.12% .

Similar stores for Neogen

a day ago at www.macroaxis.com 
Exercise of in-the-money or at-the-money derivative position by Maltese Anthony E of 1750 shares of Neogen
Macroaxis News
Filed transaction by Neogen Corp officer. Derivative codes exercise of in-the-money or at-the-money derivative security
six days ago at http://nysedaily.com 
Hot Condition Now Neogen Corporation
news
NYSE DAILY Full coverage
over a week ago at http://www.thecoinguild.com 
Stock Review Investors Taking a Second Look at Neogen Corporation After Recent Market Moves
news
The Coin GuildFull coverage
over a week ago at www.macroaxis.com 
Acquisition by Mark Mozola of 6500 shares of Neogen subject to Rule 16b-3
Macroaxis News
Filed transaction by Neogen Corp officer. Grant, award or other acquisition pursuant to Rule 16b-3
over two weeks ago at www.macroaxis.com 
Exercise of in-the-money or at-the-money derivative position by Maltese Anthony E of 4500 shares of Neogen
Macroaxis News
Filed transaction by Neogen Corp officer. Derivative codes exercise of in-the-money or at-the-money derivative security
over two weeks ago at http://extremeherald.com 
EPS for Neogen Corporation Expected At 0.28
news
Extreme Herald0.28 EPS Expected for Neogen Corporation The FinExaminerSkechers USA Shareholder Gam Holding Ag Trimmed Position Neogen Holding Has Lifted by New ... The Cardinal Weekly The Daily Biotech Pulse FDA Blessings for Mercks HIV Drug Combo, Veracytes Test Gets Medicare Coverage BenzingaFull coverage
over two weeks ago at http://markets.businessinsider.com 
Food Beverage Disinfection Market Worth 178.2 Million by 2023
businessinsider News
Markets InsiderFull coverage
over three weeks ago at www.macroaxis.com 
Sale by Edward Bradley of 5100 shares of Neogen
Macroaxis News
Filed transaction by Neogen Corp officer. General open market or private sale of non-derivative or derivative security
over three weeks ago at www.macroaxis.com 
Purchase by Steven Quinlan of 500 shares of Neogen
Macroaxis News
Filed transaction by Neogen Corp officer. General open market or private purchase of non-derivative or derivative security
over a month ago at www.macroaxis.com 
Exercise or conversion by Jack Parnell of 4000 shares of Neogen subject to Rule 16b-3
Macroaxis News
Filed transaction by Neogen Corp director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
over a month ago at http://cardinalweekly.com 
Exercise or conversion by Jack Parnell of 6000 shares of Neogen subject to Rule 16b-3
news
Filed transaction by Neogen Corp director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
over two months ago at http://news.cmlviz.com 
Trading Momentum into Earnings Optimism With Options in Neogen Corporation
news
CML NewsFull coverage
over three months ago at http://normanobserver.com 
Neogen Reaches 75.98 High on May, 30 Biocryst Pharmaceuticals Has 0.96 Sentiment
news
NormanObserver.comFull coverage

Shares Outstanding

Shares Outstanding Comparative Analysis

  Shares Outstanding 
      Neogen Comparables 
Neogen is currently under evaluation in shares outstanding category among related companies. Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted bases which include exotic instruments such as options, or convertibles bonds.

Peers

Neogen Related Equities

BIO  5.54 %   
0%
74.0%
CRL  3.05 %   
0%
41.0%
A  2.71 %   
0%
36.0%
LH  0.85 %   
0%
11.0%
FLDM  0.36 %   
0%
4.0%
DXCM  0.27 %   
0%
3.0%
ARA  1.4 %   
18.0%
0%
DRIO  3.96 %   
53.0%
0%
EXAS  4.01 %   
54.0%
0%
FLGT  7.41 %   
100.0%
0%
Please see also Neogen Hype Analysis, Neogen Correlation and Neogen Performance. Please also try Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Search macroaxis.com